Immunization To Prevent Acute COPD Exacerbations

Live Vaccines and Innate Immune Training in COPD.

NCT06257212 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF)

NCT01769196 ·Status: TERMINATED ·Phase: PHASE2

Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas Aeruginosa

NCT01315691 ·Status: WITHDRAWN ·Phase: PHASE3

Evaluation of the Efficacy and Safety of MV130 in Chronic Obstructive Pulmonary Disease (COPD)

NCT01842360 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Immunoglobulin Replacement Therapy for Immunoglobulin G Subclass 2 Deficient Patients With Bronchiectasis

NCT03737617 ·Status: WITHDRAWN ·Phase: PHASE4

A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation

NCT04656275 ·Status: TERMINATED ·Phase: PHASE1

Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge

NCT04537130 ·Status: UNKNOWN ·Phase: PHASE1

Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis

NCT01262001 ·Status: COMPLETED ·Phase: PHASE2

Phase 1, Safety and Bronchopulmonary PK Study in Healthy Volunteers

NCT03691584 ·Status: COMPLETED ·Phase: PHASE1

A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis

NCT06280391 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

NCT06360094 ·Status: TERMINATED ·Phase: PHASE2

A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-027)

NCT03449134 ·Status: COMPLETED ·Phase: PHASE3

A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

NCT03591926 ·Status: WITHDRAWN ·Phase: PHASE2

Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis

NCT03903913 ·Status: UNKNOWN ·Phase: PHASE2

A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis

NCT00769119 ·Status: COMPLETED ·Phase: PHASE2

Inhaled NAC in Treatment of IPF

NCT03720483 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Extension Study of Liposomal Amikacin for Inhalation in Cystic Fibrosis (CF) Patients With Chronic Pseudomonas Aeruginosa (Pa) Infection

NCT01316276 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections

NCT01315678 ·Status: COMPLETED ·Phase: PHASE3

CleanUP IPF for the Pulmonary Trials Cooperative

NCT02759120 ·Status: TERMINATED ·Phase: PHASE3

An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis

NCT03573505 ·Status: TERMINATED ·Phase: PHASE2

A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis

NCT03309358 ·Status: TERMINATED ·Phase: PHASE1

A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis

NCT05238675 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study to Evaluate Safety and Efficacy of AMB-05X in Subjects With Idiopathic Pulmonary Fibrosis

NCT05349760 ·Status: WITHDRAWN ·Phase: PHASE2

INB03 for the Treatment of Pulmonary Complications From COVID-19

NCT04370236 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care

NCT03711162 ·Status: TERMINATED ·Phase: PHASE3